Systems and methods of using and imaging shear-thinning biomaterial compositions are provided. More particularly, systems and methods of providing reversible birth control and/or for delivering therapeutics to reproductive organs are provided. A method includes administering a biomaterial into fallopian tubes, uterus, or vas deferens of the subject, where the biomaterial is a shear-thinning nanocomposite.

A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host. A process for controlling retrovirus transmission within a population includes the administration to a subpopulation at high risk for contracting an immunodeficiency retroviral infection the detailed combination prior to sexual exposure to a source of immunodeficiency retrovirus so as to preclude the immunodeficiency retrovirus from becoming self-replicating in a member of the subpopulation.

An external device for applying a substance to the perineum comprises: a bottom wall; and an elastic side wall extending from the bottom wall; wherein said bottom wall and side wall together form an open cup-shaped body for holding the substance.

An apparatus for sexual activity usage between a first user, the wearer, having a body orifice, such as but not exclusive to a vagina, an anus or a mouth, and a second user having a body-extending member, such as but not exclusive to a penis, a tongue or a finger, the apparatus comprising: a garment assembly being configured to be worn by the first user, the wearer, relative to the body orifice of the first user, the wearer; and a fluid-impenetrable receiver being configured to: form, at least in part, an entryway being configured to receive, at least in part, the body-extending member of the second user; be affixed to the garment assembly at a fixed position and fixed orientation relative to the body-extending member; and be spaced apart from and be positioned and remain entirely outside of the body orifice of the first user once the first user wears the garment assembly in such a way that transfer of a sexually-transmittable fluid between the first user and the second user and physical contact with any orifice is reduced. This action will mimic conventional sexual intercourse without the penetration of a body-extending member into a body orifice.

An apparatus for sexual activity usage between a first user, the wearer, having a body orifice, such as but not exclusive to a vagina, an anus or a mouth, and a second user having a body-extending member, such as but not exclusive to a penis, a tongue or a finger, the apparatus comprising: a garment assembly being configured to be worn by the first user, the wearer, relative to the body orifice of the first user, the wearer; and a fluid-impenetrable receiver being configured to: form, at least in part, an entryway being configured to receive, at least in part, the body-extending member of the second user; be affixed to the garment assembly at a fixed position and fixed orientation relative to the body-extending member; and be spaced apart from and be positioned and remain entirely outside of the body orifice of the first user once the first user wears the garment assembly in such a way that transfer of a sexually-transmittable fluid between the first user and the second user and physical contact with any orifice is reduced. This action will mimic conventional sexual intercourse without the penetration of a body-extending member into a body orifice.

A system for delivery of medication in treatment of disorders of the pelvis is disclosed. The system includes a medicament applied to an implantable device and an insertion tool. The implantable device has a first end opposite from a second end, with the first end of the implantable device insertable into tissue within the pelvis. A retrieval string is coupled to the second end of the implantable device. The insertion tool includes a shaft extending between a proximal end and a distal end, with a handle coupled to the proximal end of the insertion tool and the distal end of the insertion tool is adapted to couple with the implantable device. The handle includes a notch adapted to releasably secure the retrieval string.

A system for delivery of medication in treatment of disorders of the pelvis is disclosed. The system includes a medicament applied to an implantable device and an insertion tool. The implantable device has a first end opposite from a second end, with the first end of the implantable device insertable into tissue within the pelvis. A retrieval string is coupled to the second end of the implantable device. The insertion tool includes a shaft extending between a proximal end and a distal end, with a handle coupled to the proximal end of the insertion tool and the distal end of the insertion tool is adapted to couple with the implantable device. The handle includes a notch adapted to releasably secure the retrieval string.

A sexual aid device comprising a main body (100) and a cervical void (110), sized and shaped to shield a cervix (350) during intercourse. This self-retaining device comprises a means to prevent a penis from colliding with the cervix (350), a means to shield the anterior vagina wall from frictional contact during sexual intercourse and at least one means to retain the sexual aid device within the vagina. This device provides a non-surgical, cost-effective solution to allow for more comfortable deeper penetration by guiding the penis away from the cervix.

Systems and methods of using and imaging shear-thinning biomaterial compositions are provided. More particularly, systems and methods of providing reversible birth control and/or for delivering therapeutics to reproductive organs are provided. A method includes administering a biomaterial into fallopian tubes, uterus, or vas deferens of the subject, where the biomaterial is a shear-thinning nanocomposite.

Systems and methods of using and imaging shear-thinning biomaterial compositions are provided. More particularly, systems and methods of providing reversible birth control and/or for delivering therapeutics to reproductive organs are provided. A method includes administering a biomaterial into fallopian tubes, uterus, or vas deferens of the subject, where the biomaterial is a shear-thinning nanocomposite.